Rufus Shanks Pearson Jr, CRNA | |
1725 Pine St, Montgomery, AL 36106-1109 | |
(334) 293-8000 | |
Not Available |
Full Name | Rufus Shanks Pearson Jr |
---|---|
Gender | Male |
Speciality | Nurse Anesthetist, Certified Registered |
Location | 1725 Pine St, Montgomery, Alabama |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1982661625 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367500000X | Nurse Anesthetist, Certified Registered | 1-043795 (Alabama) | Primary |
Mailing Address | Practice Location Address |
---|---|
Rufus Shanks Pearson Jr, CRNA Po Box 235019, Montgomery, AL 36123-5019 Ph: (334) 279-1450 | Rufus Shanks Pearson Jr, CRNA 1725 Pine St, Montgomery, AL 36106-1109 Ph: (334) 293-8000 |
News Archive
The Myelodysplastic Syndromes Foundation today said significant advances are being made in understanding and treating MDS and a related condition, AML (acute myeloid leukemia). Key studies being presented this week include data on new markers and genetic mutations to predict susceptibility to MDS and response to treatment.
CoDa Therapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of therapeutics for wound care and tissue repair, today announced positive results from its Phase 2 NOVEL Study of NEXAGON® in patients with chronic venous leg ulcers. NEXAGON® is a topically applied, novel therapeutic candidate, with the potential to revolutionize the wound healing treatment paradigm by leveraging a new mechanism and target involved in the healing process.
Cell Therapeutics, Inc. (CTI) today announced an agreement with the North Central Cancer Treatment Group (NCCTG) to conduct a phase II study of pixantrone in patients with HER2-negative metastatic breast cancer who have tumor progression after at least two, but not more than three, prior chemotherapy regimens.
Pulmonary hypertension, a deadly form of high blood pressure that develops in the lungs, may be caused by an inflammation-producing molecular pathway that damages the inner lining of blood vessels, according to a new study by researchers at the Stanford University School of Medicine.
Over the last 20 years, complications have decreased and survival has improved for extremely preterm infants, according to a study in the September 8 issue of JAMA.
› Verified 5 days ago
Mrs. Amanda Marie Haigler, DNP CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1725 Pine St, Montgomery, AL 36106 Phone: 334-293-8000 | |
Crista Wanda Marquardt, C.R.N.A. Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 2105 E South Blvd, Montgomery, AL 36116 Phone: 334-288-2100 | |
Andrew Easterling, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1725 Pine St, Montgomery, AL 36106 Phone: 334-279-1450 Fax: 334-395-4115 | |
James Cowell, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1725 Pine St, Montgomery, AL 36106 Phone: 334-293-8000 | |
Thomas H. Booth Ii, C.R.N.A. Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2105 E South Blvd, Montgomery, AL 36116 Phone: 334-386-3579 | |
Susan Hamilton Mitchell, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2105 E South Blvd, Montgomery, AL 36116 Phone: 334-288-2100 | |
Hollie Nicole Sanders, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2105 E South Blvd, Baptist Hospital Dept Of Anes, Montgomery, AL 36116 Phone: 770-643-5619 |